Journals / Göztepe Tıp Dergisi / 2014 / Cilt: 29 - Sayı: 1

Evaluation of antibiotic susceptibilities of Pseudomonas aeruginosa isolates

Pseudomonas aeruginosa izolatlarının antibiyotik duyarlılıklarının değerlendirmesi

Pages
20–23
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Our study represents the first regional data for P. aeruginosa strains that would help to determine local approaches to P. aeruginosa infections and to develop policy for antibiotherapy.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: In this study; antimicrobial susceptibilities of 140 Pseudomonas aeruginosa strains isolated from various clinical samples were investigated in our hospital.
📊
Key Findings & Data:Material and Methods: Vitek 2 (bioMérieux, France) automatised system was used for the identification and antibiotic susceptibility tests, and susceptibility results were determined according to the guidelines of CLSI.
💡
Conclusion & Impact:Conclusion: Our study represents the first regional data for P. aeruginosa strains that would help to determine local approaches to P. aeruginosa infections and to develop policy for antibiotherapy.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: In this study; antimicrobial susceptibilities of 140 Pseudomonas aeruginosa strains isolated from various clinical samples were investigated in our hospital. Material and Methods: Vitek 2 (bioMérieux, France) automatised system was used for the identification and antibiotic susceptibility tests, and susceptibility results were determined according to the guidelines of CLSI. Results: Forty five (32 %) of the strains were isolated from tracheal aspirate, thirty six (26 %) from urine, thirty eight (27 %) from wound, nine (7 %) from blood, seven (5 %) from sputum, three (2 %) from pleura, two (1 %) from catheter samples. Resistance rates of the strains for ciprofloxacin, ceftazidime, piperacillin, meropenem and amikacin were found as 39, 44, 45, 37, and 13 % respectively. Conclusion: Our study represents the first regional data for P. aeruginosa strains that would help to determine local approaches to P. aeruginosa infections and to develop policy for antibiotherapy.

Özet

Amaç: Bu çalışmada; hastanemiz mikrobiyoloji laboratuvarına gelen çeşitli klinik örneklerden izole edilen 140 Pseudomonas aeruginosa izolatının antibiyotik duyarlılıkları araştırılmıştır. Gereç ve Yöntem: İdentifikasyon ve antibiyogram çalışmalarında Vitek 2 (bioMérieux, Fransa) otomatize sistemi kullanılmış, duyarlılık sonuçları CLSI kriterleri esas alınarak belirlenmiştir. Bulgular: Suşların 45'i (% 32) trakeal aspirat, 36'sı (% 26) idrar, 38'i (% 27) yara, 9'u (% 7) kan, 7'si (% 5) balgam, 3'ü (% 2) plevra ve 2'si (% 1) katater örneğinden izole edilmiştir. Çalışma kapsamında değerlendirilen suşların siprofloksasin, seftazidim, piperasilin, meropenem ve amikasine direnç oranlarının sırasıyla % 39, % 44, % 45, % 37 ve % 13 olduğu gözlenmiştir. Sonuç: Çalışmamız ile P. aeruginosa suşları için ilk bölgesel veriler sunulmakta olup, bu verilerin P. aeruginosa infeksiyonlarında yerel yaklaşımların belirlenmesinde ve antibiyotik kullanım politikalarının oluşturulmasında yardımcı olacağı düşünülmektedir.

🔖

Cite This Article

TERZİ, H. A., ÇİFTCİ, İ. H., KARAKEÇE, E. (2022). Evaluation of antibiotic susceptibilities of Pseudomonas aeruginosa isolates. Göztepe Tıp Dergisi, Cilt: 29 - Sayı: 1, 20–23. https://ajindex.com/articles/526028

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Ustaçelebi Ş (Editör). Temel ve Klinik Mikrobiyoloji. In: Erdem B. Enterobacteriaceae. Güneş Kitapevi, Ankara, 1999; 472-514
  2. Harris AA, Goodman L, Levin S. Community-acquired Pseudomonas aeruginosa pneumonia associated with the use of a home humidifier. West J Med 1984;141(4):521- 523
  3. Duerden BI (Editor). Microbiology and Microbial Infections. In: Pitt TL. Pseudomonas, Burkholderia and related genera. Vol. 2, Oxford University Press Inc., New York, 1998; 1109-1138
  4. Mandell GL, Dolan R, Bennett JE (Editors). Principles and Practices of Infectious Diseases. In: Pollack M. Pseudomonas aeruginosa. Churchill Livingstone, New York, 1995; 1820-2003
  5. Pechere JC, Köhler T. Patterns and modes of beta-lactam resistance in Pseudomonas aeruginosa. Clin Microbiol Infect 1999;5(1):15-18.
  6. CLSI. Performance Standards for Antimicrobial Susceptibility Testing; Twenty-First Informational Supplement. CLSI document M100-S21. Clinical and Laboratory Standards Institute. Wayne, PA, 2011
  7. Morrison AJ, Wenzel RP. Epidemiology of infections due to Pseudomonas aeruginosa. Rev Infect Dis 1984;6(3):627- 642
  8. Blanc DS, Petignat C, Janin B, Bille J, Fancioli P. Frequency and molecular diversity of Pseudomonas aeruginosa upon admission and during hospitalization: a prospective epidemiologic study. Clin Microbiol Infect 1998;4(5):242- 247.
  9. Wang H, Chen M, Ni Y, et al. Antimicrobial resistance among clinical isolates from the Chinese Meropenem Surveillance Study (CMSS) 2003-2008. International Journal of Antimicrobial Agents 2010;35(3):227-234.
  10. Jones RN, Stilwell MG, Rhomberg PR, Sader HS. Antipseudomonal activity of piperacillin/tazobactam: more than a decade of experience from the SENTRY Antimicrobial Surveillance Program (1997-2007). Diagnostic Microbiology and İnfectious Disease. 2009;65(3):331-4.
  11. Eyigör M, Telli M, Tiryaki Y, Okulu Y, Aydın N. Yatan hastalardan izole edilen Pseudomonas aeruginosa suşlarının antibiyotik duyarlılıkları. Ankem Derg 2009;23(3):101-105
  12. Güven Ö, Ünver D, Özdemir S, et al. Çeşitli klinik örneklerden izole edilen Pseudomonas aeruginosa kökenlerinin antibiyotiklere duyarlılıkları ve beta-laktam direnç fenotipleri. Türk Mikrobiyol Cem Derg 2008;38(3-4):112-116
  13. Zhanel GG, DeCorby M, Laing N et al. Antimicrobia